USP8 knockdown decreases Amyloid β (Aβ) production in an in vitro model of AD, presumably by promoting lysosome-dependent degradation of β-secretase, the enzyme involved in amyloid precursor protein (APP) processing [18]. Here, USP8 is linked to Alzheimer disease.